BioSniper
ZH
Toggle language
Open menu
Earnings Report
positive
Earnings Report
May 6, 2026
Company
Vir Biotechnology, Inc. (VIR)
Other upcoming events for VIR
Phase 3 Readout
Phase 3 Topline: A Phase 3 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart + Elebsiran
May 1, 2031
Phase 3 Readout
Phase 3 Topline: A Phase 3 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran C
Jul 1, 2031
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
VIR Overview
PDUFA Dates
Phase 3 Readouts
Earnings Report — VIR Earnings Report | BioSniper